Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. A. Vakula"'
Publikováno v:
Вестник университета, Vol 0, Iss 8, Pp 212-219 (2022)
The relevance of the problem under study is due to the problems that arise in the conditions of remote forms of labor interaction, as well as the role of the manager in creating an effective communication environment. The purpose of the article is to
Externí odkaz:
https://doaj.org/article/3e32510ef6784ec2b2da3f6ea57621c4
Publikováno v:
Neuroscience and Behavioral Physiology. 49:129-135
Objectives. To assess the efficacy and safety of hopantenic acid (Pantogam) compared with placebo in the treatment of ADHD for four months in children aged 6–12 years during a prospective, multicenter, comparative, double-blind, placebo-controlled,
Autor:
T. I. Glazunova, J. A. Storozhuk, E. U. Nikiforova, I. N. Vakula, D. I. Nikiforova, U. A. Vorona, E. O. Bojko
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(2)
To evaluate the efficacy and tolerability of intravenous lacosamide (vimpat) in inpatients with frequent partial-onset seizures and affective and cognitive disorders.Fifteen patients were enrolled including 14 patients diagnosed with «organic person
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 115(11)
To assess the efficacy and safety of children tenoten in the treatment of children and adolescents with anxiety disorders.It was conducted a multicenter, double-blind, placebo-controlled trial of the drug tenoten children at a dose of 1 tablet 3 time
Autor:
I. A. Vakula
Publikováno v:
Proceedings of the Steklov Institute of Mathematics. 272:271-286
It is proved that every finite group isospectral to an alternating group An of degree n greater than 21 has a chief factor isomorphic to an alternating group Ak, where k ≤ n and the half-interval (k, n] contains no primes.
Publikováno v:
Neuroscience and Behavioral Physiology. 40:1034-1037
Children and adolescents (25 boys, nine girls, aged from six to 17 years) with attention deficit hyperactivity disorder (ADHD) were treated with Strattera at the optimal dose of 1.2 mg/day in out-patient conditions. After use of Strattera for three m
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 117:39
To assess the efficacy and safety of hopantenic acid (pantogam) compared to placebo in the treatment of attention deficit hyperactivity disorder (ADHD) in children, aged from 6 to 12 years, during 4 month in the prospective multicenter comparative do
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 109(8)
A group of children and adolescents with ADHD (25 boys and 9 girls), aged 6-17 years, were treated with strattera in the optimum dose (1,2 mg/day) on an outpatient basis. The assessment of treatment effectiveness showed the marked and moderately pron